PeptidesWeight LossLongevitySexual Health - MenSexual Health - WomenHair RestorationAnti-ParasiticSleepHow it worksFAQAboutContactLog in
Peptide therapy · Subcutaneous injection
PrescriptionU.S. Licensed PharmacyProvider-ReviewedEvidence Explained

BPC-157: a 15-amino-acid peptide studied in laboratory research

BPC-157 is a synthetic pentadecapeptide. Preclinical research has explored growth-factor and nitric-oxide signaling, while human evidence for subcutaneous use remains limited. Available by prescription only after provider review.

From $188 first month
$188First month, renews at $220/mo
Start Assessment
✓ U.S.-licensed providers✓ HIPAA-secure✓ Free discreet shipping✓ Ongoing care included
BPC-157 product image
Mechanism and evidence

What the research says about BPC-157

Mechanism education without turning preclinical findings into promises.

✓

A synthetic pentadecapeptide

BPC-157 is a 15-amino-acid synthetic peptide derived from a partial sequence of a gastric protein. It is not an FDA-approved medication.

✓

Growth-factor signaling research

Cell and animal studies have explored relationships between BPC-157 and VEGF, EGF, and nitric-oxide signaling. These are mechanistic findings, not proof of healing or recovery benefits in humans.

✓

Human evidence remains limited

Small studies have used rectal, intra-articular, intravesical, and intravenous administration. FDA found no studies using the proposed subcutaneous route, and long-term safety and effectiveness remain unestablished.

✓

A provider-directed protocol

Your provider reviews your history, medications, and goals before determining whether this compounded injectable option is appropriate and how it should be used.

About this treatment

Provider-reviewed care, built around the evidence

✓

Provider oversight

Prescribed only when a licensed provider determines it is appropriate based on your history, medications, and treatment goals.

✓

No mystery vials

When prescribed, your medication is prepared by and shipped directly from a licensed U.S. pharmacy in discreet packaging.

✓

Clear ingredient education

Each product page separates mechanism research from human evidence so the unknowns stay visible.

✓

Ongoing care included

Message your care team with questions about your protocol, refills, or side effects.

How it works

Care without the waiting room

Get started in 4 simple steps. No office visits required.

01

Start your assessment

A 5-minute online health questionnaire, no appointment, no waiting room.

02

Provider review

A licensed provider in your state reviews your history and prescribes if appropriate.

03

Pharmacy ships direct

When prescribed, your medication ships from a licensed U.S. pharmacy in discreet packaging.

04

Ongoing support

Message your care team anytime. Dose questions and refills are handled online.

FAQ

Questions about BPC-157

What does the research actually show?

Most mechanism research is preclinical. Small human reports use other routes and do not establish subcutaneous effectiveness or long-term safety.

Is this medication FDA-approved?

No. This compounded medication is not FDA-approved. Compounded drugs are prepared for individual patients, and FDA does not verify their safety, effectiveness, or quality before marketing.

How do I know whether it is appropriate for me?

Complete the online assessment. A licensed provider reviews your medical history, medications, and goals before deciding whether to prescribe.

Where will I see pricing and protocol details?

Current pricing is shown on this page when a customer offer exists. Your provider-directed protocol and any additional details are confirmed during assessment and review.

Important safety informationBPC-157 is available by prescription only after evaluation by a licensed provider. This compounded medication is not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. A reliable common side-effect profile for subcutaneous BPC-157 has not been established. Injection-site reactions and allergic reactions are possible. FDA has identified limited human safety information, potential immunogenicity, peptide-related impurity and API-characterization concerns, and animal findings related to coagulation and liver markers. Tell your provider about bleeding or liver conditions and all medications. BPC-157 is prohibited at all times under WADA S0. Side-effect profiles for research-stage peptides are not fully established. Tell your provider about all medical conditions and medications before use. These peptides are prohibited in tested sport; check anti-doping rules if you compete. Individual results vary. This page is educational and is not medical advice.

Start with a provider review

Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.

Start Assessment
Peptide therapy

Related treatments

TB-500 product image

TB-500

Subcutaneous injection

Thymosin beta-4 fragment. Injectable protocol.

From $199 first month
Coming soonKPV product image

KPV

Provider-reviewed peptide protocol

Three amino acids. One alpha-MSH fragment.

Coming soon
Coming soonEpitalon product image

Epitalon

Provider-reviewed peptide protocol

Four amino acids. One synthetic peptide.

Coming soon
BPC-157From $188 first month
Start Assessment